vs
BOSTON OMAHA Corp(BOC)与STANDARD BIOTOOLS INC.(LAB)财务数据对比。点击上方公司名可切换其他公司
BOSTON OMAHA Corp的季度营收约是STANDARD BIOTOOLS INC.的1.5倍($29.7M vs $19.6M),BOSTON OMAHA Corp净利率更高(-23.1% vs -177.4%,领先154.4%),BOSTON OMAHA Corp同比增速更快(6.4% vs -11.5%),BOSTON OMAHA Corp自由现金流更多($-10.0M vs $-23.1M),过去两年BOSTON OMAHA Corp的营收复合增速更高(7.8% vs -12.2%)
波士顿奥马哈公司是一家上市多元化控股企业,核心业务板块涵盖户外广告、担保保险、住宅地产开发、固定无线宽带服务,主要服务美国市场,通过战略收购与业务有机增长为股东创造长期价值。
Standard BioTools(原Fluidigm公司)是一家美国生命科学工具企业,主营流式细胞术与组织成像分析用质谱流式系统,以及配套的检测试剂盒与试剂,同时供应自动化基因组分析仪器、各类微流控芯片(又称集成流体电路)及配套试剂耗材,全系列产品及应用场景均可提供定制检测方案与相关服务。
BOC vs LAB — 直观对比
营收规模更大
BOC
是对方的1.5倍
$19.6M
营收增速更快
BOC
高出17.8%
-11.5%
净利率更高
BOC
高出154.4%
-177.4%
自由现金流更多
BOC
多$13.0M
$-23.1M
两年增速更快
BOC
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $29.7M | $19.6M |
| 净利润 | $-6.9M | $-34.7M |
| 毛利率 | 64.0% | 48.5% |
| 营业利润率 | -4.2% | -168.5% |
| 净利率 | -23.1% | -177.4% |
| 营收同比 | 6.4% | -11.5% |
| 净利润同比 | -228.1% | -28.8% |
| 每股收益(稀释后) | $-0.23 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BOC
LAB
| Q4 25 | $29.7M | — | ||
| Q3 25 | $28.7M | $19.6M | ||
| Q2 25 | $28.2M | $21.8M | ||
| Q1 25 | $27.7M | $40.8M | ||
| Q4 24 | $27.9M | — | ||
| Q3 24 | $27.7M | $22.1M | ||
| Q2 24 | $27.1M | $22.5M | ||
| Q1 24 | $25.6M | $45.5M |
净利润
BOC
LAB
| Q4 25 | $-6.9M | — | ||
| Q3 25 | $-2.6M | $-34.7M | ||
| Q2 25 | $-2.3M | $-33.5M | ||
| Q1 25 | $-669.3K | $-26.0M | ||
| Q4 24 | $5.3M | — | ||
| Q3 24 | $-1.6M | $-26.9M | ||
| Q2 24 | $-2.2M | $-45.7M | ||
| Q1 24 | $-2.8M | $-32.2M |
毛利率
BOC
LAB
| Q4 25 | 64.0% | — | ||
| Q3 25 | 66.2% | 48.5% | ||
| Q2 25 | 66.1% | 48.8% | ||
| Q1 25 | 67.3% | 48.4% | ||
| Q4 24 | 69.5% | — | ||
| Q3 24 | 67.5% | 54.9% | ||
| Q2 24 | 68.2% | 46.1% | ||
| Q1 24 | 67.9% | 53.1% |
营业利润率
BOC
LAB
| Q4 25 | -4.2% | — | ||
| Q3 25 | -3.7% | -168.5% | ||
| Q2 25 | -2.9% | -118.1% | ||
| Q1 25 | -2.9% | -80.8% | ||
| Q4 24 | -4.6% | — | ||
| Q3 24 | -2.7% | -120.9% | ||
| Q2 24 | -16.2% | -134.5% | ||
| Q1 24 | -8.1% | -132.2% |
净利率
BOC
LAB
| Q4 25 | -23.1% | — | ||
| Q3 25 | -9.0% | -177.4% | ||
| Q2 25 | -8.2% | -153.7% | ||
| Q1 25 | -2.4% | -63.8% | ||
| Q4 24 | 19.1% | — | ||
| Q3 24 | -5.8% | -122.0% | ||
| Q2 24 | -8.3% | -203.3% | ||
| Q1 24 | -11.0% | -70.6% |
每股收益(稀释后)
BOC
LAB
| Q4 25 | $-0.23 | — | ||
| Q3 25 | $-0.08 | $-0.09 | ||
| Q2 25 | $-0.07 | $-0.09 | ||
| Q1 25 | $-0.02 | $-0.07 | ||
| Q4 24 | $0.17 | — | ||
| Q3 24 | $-0.05 | $-0.07 | ||
| Q2 24 | $-0.07 | $-0.12 | ||
| Q1 24 | $-0.09 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $56.8M | $129.4M |
| 总债务越低越好 | $25.7M | — |
| 股东权益账面价值 | $516.1M | $399.7M |
| 总资产 | $713.1M | $539.6M |
| 负债/权益比越低杠杆越低 | 0.05× | — |
8季度趋势,按日历期对齐
现金及短期投资
BOC
LAB
| Q4 25 | $56.8M | — | ||
| Q3 25 | $67.6M | $129.4M | ||
| Q2 25 | $68.6M | $158.6M | ||
| Q1 25 | $69.2M | $150.9M | ||
| Q4 24 | $73.2M | — | ||
| Q3 24 | $58.6M | $210.6M | ||
| Q2 24 | $53.1M | $269.8M | ||
| Q1 24 | $53.4M | $287.1M |
总债务
BOC
LAB
| Q4 25 | $25.7M | — | ||
| Q3 25 | $25.9M | — | ||
| Q2 25 | $26.1M | — | ||
| Q1 25 | $26.3M | — | ||
| Q4 24 | $26.5M | — | ||
| Q3 24 | $26.7M | $55.2M | ||
| Q2 24 | $26.9M | $55.1M | ||
| Q1 24 | $27.1M | $55.0M |
股东权益
BOC
LAB
| Q4 25 | $516.1M | — | ||
| Q3 25 | $528.4M | $399.7M | ||
| Q2 25 | $531.0M | $424.5M | ||
| Q1 25 | $533.3M | $454.6M | ||
| Q4 24 | $532.8M | — | ||
| Q3 24 | $527.7M | $489.3M | ||
| Q2 24 | $530.5M | $510.3M | ||
| Q1 24 | $536.2M | $577.3M |
总资产
BOC
LAB
| Q4 25 | $713.1M | — | ||
| Q3 25 | $721.4M | $539.6M | ||
| Q2 25 | $730.6M | $557.0M | ||
| Q1 25 | $730.8M | $579.6M | ||
| Q4 24 | $728.3M | — | ||
| Q3 24 | $711.9M | $681.5M | ||
| Q2 24 | $723.1M | $708.7M | ||
| Q1 24 | $757.3M | $777.7M |
负债/权益比
BOC
LAB
| Q4 25 | 0.05× | — | ||
| Q3 25 | 0.05× | — | ||
| Q2 25 | 0.05× | — | ||
| Q1 25 | 0.05× | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | 0.05× | 0.11× | ||
| Q2 24 | 0.05× | 0.11× | ||
| Q1 24 | 0.05× | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $17.9M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $-10.0M | $-23.1M |
| 自由现金流率自由现金流/营收 | -33.8% | -118.1% |
| 资本支出强度资本支出/营收 | 93.9% | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-17.6M | $-111.1M |
8季度趋势,按日历期对齐
经营现金流
BOC
LAB
| Q4 25 | $17.9M | — | ||
| Q3 25 | $4.9M | $-22.2M | ||
| Q2 25 | $4.6M | $-20.7M | ||
| Q1 25 | $2.6M | $-30.3M | ||
| Q4 24 | $21.2M | — | ||
| Q3 24 | $5.2M | $-27.9M | ||
| Q2 24 | $4.5M | $-39.0M | ||
| Q1 24 | $2.4M | $-62.5M |
自由现金流
BOC
LAB
| Q4 25 | $-10.0M | — | ||
| Q3 25 | $-489.4K | $-23.1M | ||
| Q2 25 | $-2.7M | $-22.6M | ||
| Q1 25 | $-4.3M | $-35.3M | ||
| Q4 24 | $-11.0M | — | ||
| Q3 24 | $-1.2M | $-30.1M | ||
| Q2 24 | $-4.3M | $-41.0M | ||
| Q1 24 | $-6.0M | $-63.3M |
自由现金流率
BOC
LAB
| Q4 25 | -33.8% | — | ||
| Q3 25 | -1.7% | -118.1% | ||
| Q2 25 | -9.7% | -103.6% | ||
| Q1 25 | -15.5% | -86.6% | ||
| Q4 24 | -39.2% | — | ||
| Q3 24 | -4.4% | -136.4% | ||
| Q2 24 | -15.9% | -182.2% | ||
| Q1 24 | -23.6% | -138.9% |
资本支出强度
BOC
LAB
| Q4 25 | 93.9% | — | ||
| Q3 25 | 18.9% | 4.5% | ||
| Q2 25 | 25.9% | 8.7% | ||
| Q1 25 | 24.7% | 12.4% | ||
| Q4 24 | 115.3% | — | ||
| Q3 24 | 23.2% | 10.2% | ||
| Q2 24 | 32.6% | 8.6% | ||
| Q1 24 | 33.1% | 1.7% |
现金转化率
BOC
LAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 3.97× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BOC
| Billboard Rentals | $11.9M | 40% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $10.0M | 34% |
| GIG | $7.3M | 25% |
| Other | $608.4K | 2% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |